New York Times: Boosters Are Complicating Efforts to Persuade the Unvaccinated to Get Shots

New York Times: Boosters Are Complicating Efforts to Persuade the Unvaccinated to Get Shots. ” The overwhelming majority of eligible adults who remain unvaccinated in the United States are hard-core refusers, and the arrival of boosters is making efforts to coax them as well as those who are still hesitating even more difficult. In the September vaccine monitor survey from the Kaiser Family Foundation, 71 percent of unvaccinated respondents said the need for boosters indicated that the vaccines were not working.”

WRAL: Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worry

WRAL: Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worry. “There’s little doubt now — study after study, in real life and in lab dishes, in the US and elsewhere — that people’s immunity starts to wane just months after they finish the two-dose series of Pfizer COVID-19 vaccine. While getting two doses of vaccine creates a strong immune response that reduces the risk of severe disease by more than 90%, the protection against milder and asymptomatic infections drops off gradually.”

NBC News: Covid-19 booster shots now surpassing initial vaccination doses by nearly half

NBC News: Covid-19 booster shots now surpassing initial vaccination doses by nearly half. “An NBC News analysis of Centers for Disease Control and Prevention data shows that the number of people receiving booster shots is outpacing those getting their first or second doses of the initial vaccination, and is contributing to a modest increase in Covid vaccinations in October. Of the 6.7 million shots administered from Sept. 30 to Oct. 6, nearly 2.7 million were booster shots. That’s compared to the nearly 2 million first doses and nearly 2 million second doses in the same period.”

CNN: FDA vaccine advisers vote to recommend booster doses of Covid-19 vaccine in people 65 and older and those at high risk

CNN: FDA vaccine advisers vote to recommend booster doses of Covid-19 vaccine in people 65 and older and those at high risk. “Vaccine advisers to the US Food and Drug Administration voted Friday to recommend emergency use authorization of a booster dose of Pfizer’s vaccine to people 65 and older and those at high risk of severe Covid-19 six months after they get their first two shots. But the FDA’s Vaccines and Related Biological Products Advisory Committee rejected a broader application to approve booster doses of Pfizer’s vaccines for everyone 16 and older six months after they are fully vaccinated.”

CNN: FDA’s vaccine advisers meet to decide whether Americans need boosters

CNN: FDA’s vaccine advisers meet to decide whether Americans need boosters. “The all-day meeting will be packed with presentations. They’ll include Pfizer/BioNTech, which is arguing that there’s enough evidence of waning immunity to justify giving booster doses to people. The FDA will present its own take on the data that’s been sent to the agency so far — although written briefing materials published before the meeting suggest the agency is remaining neutral for the time being.”

Wake Forest University: In the battle against Covid-19, the economics of boosters

Wake Forest University: In the battle against Covid-19, the economics of boosters. “There has been some concern that the push for a booster shot may be motivated by profit rather than an individual’s health and long-term wellbeing. Economics professor Tina Marsh Dalton’s research is at the intersection of health economics and market organization. She holds a joint appointment with the Wake Forest School of Medicine and her work focuses on improving health care by analyzing how markets for health care goods and services work. ”